Biotinylated Anti-CD19(tafasitamab biosimilar) mAb

Price: 50 μg ￥890.00 ; 100 μg ￥1699.00

SKU: BME100683B Category: Biosimilar reference antibodies

Uniprot ID	P15391
Common Name	ICP-B04;ICP B04;MOR 208;MOR208;MOR-208;XENP-5574;XENP5574;XENP 5574;XmAb-5574;XmAb5574;XmAb 5574
Synonyms	CD19;B4;CVID3;MGC12802
Applications	N/A
Recommended Dilutions	N/A
Formulation & Reconstitution	Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Host Species	N/A
IgG type	IgG1
Reactivity	Human
Target	CD19
Description	Biotinylated Anti-CD19(tafasitamab biosimilar) mAb
Delivery	6-8 weeks
Storage & Shipping	Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only
Conjugate	Biotinylated
DIMA Disclaimer	All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.